Publications by authors named "Kazuma Ojima"

Claim this Profile
E
Effects of combination of mitiglinide with various oral antidiabetic drugs in streptozotocin-nicotinamide-induced type 2 diabetic rats and Zucker fatty rats.
Kenji Akahane, Kazuma Ojima, Ayaka Yokoyama, Toshihiro Inoue, Sumiyoshi Kiguchi

Clin Exp Pharmacol Physiol· December 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comparison of the Effects of Mitiglinide and Glibenclamide Administered in Combination with the Dipeptidyl Peptidase-IV Inhibitor Sitagliptin in Rats with Streptozotocin-Nicotinamide-Induced Type 2 Diabetes.
Kenji Akahane, Kazuma Ojima, Ayaka Yokoyama, Toshihiro Inoue, Sumiyoshi Kiguchi

Drug Res (Stuttg)· July 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Sergliflozin etabonate, a selective SGLT2 inhibitor, improves glycemic control in streptozotocin-induced diabetic rats and Zucker fatty rats.
Yoshikazu Fujimori, Kenji Katsuno, Kazuma Ojima, Ikumi Nakashima, Shigeru Nakano

Eur J Pharmacol· May 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effects of mitiglinide and sulfonylureas in isolated canine coronary arteries and perfused rat hearts.
Itaru Maruyama, Yoshitaka Tomiyama, Kazuyasu Maruyama, Kazuma Ojima, Kumi Kobayashi, Masami Kojima

Eur J Pharmacol· February 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[Pharmacological and clinical profile of mitiglinide calcium hydrate (Glufast), a new insulinotropic agent with rapid onset].
Kazuma Ojima, Yuji Kiyono, Masami Kojima

Nihon Yakurigaku Zasshi· October 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Study of the insulinotropic effect of the novel antihyperglycemic agent KAD-1229 using HIT T15 cells, a hamster's insulinoma cell line.
Kiyoshi Ichikawa, Tokuhisa Yamato, Atsutoshi Tsuji, Kazuma Ojima, Hiroshi Kusama, Masami Kojima

Arzneimittelforschung· October 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effect of KAD-1229, a novel hypoglycaemic agent, on plasma glucose levels after meal load in type 2 diabetic rats.
Kiyoshi Ichikawa, Tokuhisa Yamato, Kazuma Ojima, Atsutoshi Tsuji, Kohtaro Ishikawa, Masami Kojima

Clin Exp Pharmacol Physiol· August 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis